Abstract:

The article discusses the features of the use of information resources in developing new geriatric drugs. It is shown that the development of new information support geriatric drugs should be based on open access to electronic resources through the Internet: chemoinformatic electronic databases and Internet services predict the biological activity of substances. It is concluded that the proposed approach can significantly reduce material and time spent on the search for new pleiotropic effects of active pharmaceutical ingredients and development of new high-performance low toxicity drugs for the elderly and senile age.

Keywords: in silico, virtual screening, elderly people, active pharmaceutical ingredients, gerontology